This article is more than 5 years old. Information may no longer be current.
FDA approves study of Orion cortical visual prosthesis system
Click Here to Manage Email Alerts
The FDA has granted full approval for the first human clinical feasibility study of the Orion cortical visual prosthesis system, according to a press release from Second Sight Medical Products.
The Orion device converts images captured by a miniature video camera mounted on a patient’s glasses into a series of small electrical pulses, transmitting those pulses to an array of electrodes implanted on the surface of the visual cortex, the release said. This is intended to result in the perception of light patterns.
Two U.S. sites, the University of California at Los Angeles and Baylor College of Medicine in Houston, can enroll up to five total patients in the study.
“We remain on track toward achieving our stated goal of implanting our fist Orion patient before year end and the potential opportunity to provide useful vision to millions of blind individuals worldwide who have no other option today,” Will McGuire, Second Sight president and CEO, said in the release.